TMPRSS4 and non-small cell lung carcinoma: Because a reliable antibody against TMPRSS4 is not yet available, we evaluated mRNA levels of this protease by qRT–PCR in a clinical sample set including normal (n=15) and NSCLC (n=30; 11 AC+18 SCC+1 sarcomatoid epidermoid carcinoma histology) samples.